CollPlant Biotechnologies Ltd Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
CollPlant Biotechnologies Ltd (CLGN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 3.38 million shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-03-26
- CollPlant Biotechnologies Ltd antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-06-30 was 3.31M shares, a 62.04% increase year-over-year.
- CollPlant Biotechnologies Ltd antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-06-30 was 2.04M shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month |
|---|---|---|---|
| 2025-12-31 | 3.38M shares 20-F · filed 2026-03-26 | ||
| 2025-06-30 | 3.31M shares 6-K · filed 2025-08-20 | 3.31M shares 6-K · filed 2025-08-20 | |
| 2024-12-31 | 2.20M shares 20-F · filed 2026-03-26 | ||
| 2024-06-30 | 2.04M shares 6-K · filed 2025-08-20 | 2.04M shares 6-K · filed 2025-08-20 | |
| 2023-12-31 | 2.01M shares 20-F · filed 2026-03-26 |